IOBTQ
PINK IO Biotech, Inc.$0.0002 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0002, and at the day’s high of $0.0002
- YTD change
- -98.82%
- vs 20-day SMA
- +90.11%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-0.02 (-98.82%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.0% away from all-time highs of $0.0203
- IOBTQ is down 99% since the beginning of the year
- IOBTQ is down 99% over the past 12 months
- IOBTQ is up 100% over the past 1 month
- 1% of all IOBTQ investors are betting against IOBTQ
IOBTQ reads n/a: the 12-month move is -98.8%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- +0.00%
- vs 8-day SMA
- +33.33%
No alerts for IOBTQ in the last day.
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.